You are currently being redirected to the new CV Therapeutics Investor Relations site

Executive Management

Louis G. Lange, M.D., Ph.D.
Chairman and Chief Executive Officer
Luiz Belardinelli, M.D.
Senior Vice President
Pharmacological and Translational Biomedical Research
CVT Distinguished Fellow of Cardiovascular Science
Brent K. Blackburn, Ph.D.
Senior Vice President
Drug Discovery and Development
Carol D. Karp
Vice President
Regulatory Affairs
Diane L. Liguori
Senior Vice President
Human Resources
David C. McCaleb
Senior Vice President
Commercial Operations
Daniel K. Spiegelman
Senior Vice President and Chief Financial Officer
Peter M. Strumph
Senior Vice President
Operations
Tricia Borga Suvari, Esq.
Senior Vice President
General Counsel

Board of Directors

Santo J. Costa
Retired Vice Chairman
Quintiles Transnational Corp.
Joseph M. Davie, M.D., Ph.D.
Retired Senior Vice President
Department of Research
Biogen, Inc. (now Biogen Idec Inc.)
Thomas L. Gutshall
Chairman
Cepheid Corporation
Peter Barton Hutt, Esq.
Senior Counsel
Covington & Burling
Louis G. Lange, M.D., Ph.D.
Chairman and Chief Executive Officer
CV Therapeutics, Inc.
Kenneth B. Lee, Jr.
General Partner
Hatteras BioCapital
Barbara J. McNeil, M.D., Ph.D.
Ridley Watts Professor of
Health Care Policy
Chairman of the Department
of Health Care Policy
Harvard Medical School
Thomas E. Shenk, Ph.D.
Elkins Professor of Molecular Biology
Princeton University

Scientific Advisory Board

Stuart A. Aaronson, M.D.
Professor and Director
Derald H. Ruttenberg Cancer Center
Mount Sinai School of Medicine
Victor J. Dzau, M.D.
Hersey Professor of the Theory and Practice of Medicine
Harvard Medical School
Chairman, Department of Medicine
Physician-in-Chief, Director of Research
Brigham and Women’s Hospital
Christopher Fielding, Ph.D.
Neider Professor of Cardiovascular Physiology
Cardiovascular Research Institute
School of Medicine
University of California, San Francisco
Garret FitzGerald, M.D.
Robinette Professor of Cardiovascular Medicine
Chair, Department of Pharmacology
Director, Center of Experimental Therapeutics
University of Pennsylvania School of Medicine
Richard Havel, M.D.
Professor of Medicine, Emeritus
Cardiovascular Research Institute
School of Medicine
University of California, San Francisco
Richard M. Lawn, Ph.D.
Vice President, Discovery Research
CV Therapeutics, Inc.
Eric J. Topol, M.D.
Provost and Chief Academic Officer
Chairman, Department of Cardiovascular Medicine
The Cleveland Clinic Foundation
Sir John Vane, F.R.S.
President
The William Harvey Research Foundation
Barts and The London, Queen Mary
University of London

Copyright 1999-2004, CV Therapeutics, Inc.